Table 1.
Comparisons of general data and laboratory indicators of patients in each group (x ± S.D.)
| Group | Gender (male/ female) | Age (year) | Disease course (year) | BMI (kg/m2) | FBG (mmol/l) | HbA1c (%) | TC (mmol/l) | LDL-C (mmol/l) | FPG (mmol/l) |
TG (mmol/l) | BUN (mmol/l) | FINS (mIU/l) | Cr (μmol/l) | HOMA-IR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | 60/55 | 48.53 ± 7.26 | / | 22.82 ± 2.33 | 4.74 ± 0.75 | 4.30 ± 0.42 | 4.13 ± 0.88 | 3.21 ± 0.55 | 5.02 ± 0.68 | 1.45 ± 0.44 | 4.89 ± 1.17 | 5.50 ± 0.88 | 58.82 ± 7.65 | 1.25 ± 0.37 |
| NDR | 34/31 | 47.76 ± 8.05 | 4.16 ± 1.21* | 22.67 ± 1.98 | 7.12 ± 0.68* | 6.25 ± 0.58* | 4.25 ± 1.02 | 3.26 ± 0.61 | 5.31 ± 0.73 | 1.48 ± 0.32 | 5.26 ± 1.34 | 5.66 ± 1.02 | 59.07 ± 7.88 | 1.37 ± 0.43 |
| BDR | 32/41 | 48.83 ± 7.13 | 9.13 ± 2.54*† | 23.06 ± 1.85 | 7.25 ± 0.84* | 7.02 ± 0.66*† | 4.32 ± 0.94 | 3.30 ± 0.63 | 6.17 ± 0.75*† | 1.51 ± 0.34 | 5.33 ± 1.38 | 5.71 ± 1.14 | 61.55 ± 8.39 | 1.60 ± 0.50*† |
| PDR | 28/23 | 50.75 ± 10.18 | 13.58 ± 3.82*†‡ | 23.13 ± 2.02 | 7.33 ± 1.05* | 8.16 ± 0.79*†‡ | 4.43 ± 1.08 | 3.38 ± 0.72 | 6.86 ± 0.96*†‡ | 1.55 ± 0.45 | 5.41 ± 1.71 | 5.78 ± 1.21 | 62.43 ± 10.06 | 1.81 ± 0.62*† |
*, compared with the control group, P<0.05; †, compared with the NDR group, P<0.05; ‡, compared with the BDR group, P<0.05.